Basic guidelines for diabetes care.

GUIDELINE TITLE
Basic guidelines for diabetes care.

BIBLIOGRAPHIC SOURCE(S)
Diabetes Coalition of California, California Diabetes Program. Basic guidelines for diabetes care. Sacramento (CA): Diabetes Coalition of California, California Diabetes Program; 2008.

GUIDELINE STATUS
This is the current release of the guideline.

This guideline updates a previous version: Diabetes Coalition of California, California Diabetes Program. Basic guidelines for diabetes care. Sacramento (CA): Diabetes Coalition of California, California Diabetes Program; 2005. 16 p.

The Basic Guidelines Packet is updated regularly and may be downloaded at www.caldiabetes.org.

** REGULATORY ALERT **
FDA WARNING/REGULATORY ALERT
Note from the National Guideline Clearinghouse: This guideline references a drug(s)/intervention(s) for which important revised regulatory and/or warning information has been released.

July 31, 2008, Erythropoiesis Stimulating Agents (ESAs): Amgen and the U.S. Food and Drug Administration (FDA) informed healthcare professionals of modifications to certain sections of the Boxed Warnings, Indications and Usage, and Dosage and Administration sections of prescribing information for Erythropoiesis Stimulating Agents (ESAs). The changes clarify the FDA-approved conditions for use of ESAs in patients with cancer and revise directions for dosing to state the hemoglobin level at which treatment with an ESA should be initiated.
April 10, 2008, Exubera (insulin inhalation): Pfizer informed healthcare professionals and patients of updated safety information in the WARNINGS section of prescribing information for Exubera. This warning relates to a small number of primary lung malignancies that have been discovered in users of Exubera in clinical trials and post-marketing reports.

abrir aquí para acceder al documento NGC AHRQ completo:
Basic guidelines for diabetes care.